On the 15th June, a new glaucoma procedure was performed for the first time in Malta, as part of a surgeon training session organised by Allergan. The new XEN implant forms part of Allergan’s Eyecare portfolio distributed by Vivian Corporation.
NICE recommends Roche Diagnostic’s blood test to help rule-out pre-eclampsia in women between their 20th and 35th week of pregnancy. This blood test is more specifically known as the Elecsys immunoassay sFIt-1/PIGF ratio (Roche Diagnostics).
Vivian Corporation is an established leader in the marketing of diverse brands which are driven with one unifying goal, to improve the quality of life by creating better opportunities for our customers, patients and consumers alike.
At Vivian we have a specially dedicated team that offers solutions to healthcare professionals by providing the right diagnosis at the right time and by offering the right high quality device to improve patients’ comfort.